Summary
A greater understanding of hematopoietic stem cell (HSC) regulation is required for dissecting protective versus detrimental immunity to pathogens that cause chronic infections such as
Mycobacterium tuberculosis
(
Mtb
). We have shown that systemic administration of Bacille Calmette-Guérin (BCG) or β-glucan reprograms HSCs in the bone marrow (BM) via a type II interferon (IFN-II) or interleukin-1 (IL1) response, respectively, which confers protective trained immunity against
Mtb
. Here, we demonstrate that, unlike BCG or β-glucan,
Mtb
reprograms HSCs via an IFN-I response that suppresses myelopoiesis and impairs development of protective trained immunity to
Mtb
. Mechanistically, IFN-I signaling dysregulates iron metabolism, depolarizes mitochondrial membrane potential, and induces cell death specifically in myeloid progenitors. Additionally, activation of the IFN-I/iron axis in HSCs impairs trained immunity to
Mtb
infection. These results identify an unanticipated immune evasion strategy of
Mtb
in the BM that controls the magnitude and intrinsic anti-microbial capacity of innate immunity to infection.